))
Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
Manage episode 429238140 series 2910558
Inhoud geleverd door CancerCare. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door CancerCare of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
- Overview of Diffuse Large B-Cell Lymphoma (DLBCL), Including Staging and Grading, In the Context of COVID, Seasonal Flu and RSV - Current Standard of Care, New & Emerging Treatment Approaches - Treatment Options for Relapsed Refractory DLBCL, Including Bispecific Antibodies - Understanding How Bispecific Antibodies Work in the Treatment of Relapsed Refractory DLBCL - The Role of Clinical Trials: How Research Contributes to Treatment Options - Tips to Prevent & Manage Treatment Side Effects, Symptoms, Discomfort & Pain - Talking with Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions for Our Panel of Experts
…
continue reading
135 afleveringen
Delen
